Federated Hermes’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.19M Sell
123,072
-97,003
-44% -$1.73M ﹤0.01% 919
2025
Q1
$3.92M Sell
220,075
-687,912
-76% -$12.3M 0.01% 772
2024
Q4
$27.1M Sell
907,987
-89,457
-9% -$2.67M 0.06% 348
2024
Q3
$15.6M Buy
997,444
+254,517
+34% +$3.98M 0.03% 478
2024
Q2
$12.7M Buy
742,927
+40,870
+6% +$700K 0.03% 491
2024
Q1
$11M Buy
702,057
+85,265
+14% +$1.33M 0.03% 550
2023
Q4
$9.21M Buy
616,792
+548,852
+808% +$8.19M 0.02% 573
2023
Q3
$1.1M Buy
+67,940
New +$1.1M ﹤0.01% 1084
2022
Q3
Sell
-85
Closed -$6K 2212
2022
Q2
$6K Buy
+85
New +$6K ﹤0.01% 1880
2021
Q2
Sell
-71,825
Closed -$9.49M 2291
2021
Q1
$9.49M Sell
71,825
-23,797
-25% -$3.15M 0.02% 675
2020
Q4
$16.5M Buy
95,622
+29,774
+45% +$5.15M 0.03% 516
2020
Q3
$7.33M Buy
+65,848
New +$7.33M 0.02% 647
2020
Q1
Sell
-7,599
Closed -$640K 2320
2019
Q4
$640K Sell
7,599
-108,542
-93% -$9.14M ﹤0.01% 1400
2019
Q3
$8.69M Buy
116,141
+114,773
+8,390% +$8.58M 0.02% 609
2019
Q2
$86K Sell
1,368
-57,494
-98% -$3.61M ﹤0.01% 1624
2019
Q1
$2.84M Buy
58,862
+58,846
+367,788% +$2.83M 0.01% 933
2018
Q4
$1K Sell
16
-179,421
-100% -$11.2M ﹤0.01% 2134
2018
Q3
$9.4M Buy
179,437
+58,319
+48% +$3.06M 0.02% 592
2018
Q2
$3.79M Buy
121,118
+121,068
+242,136% +$3.79M 0.01% 769
2018
Q1
$1K Sell
50
-46
-48% -$920 ﹤0.01% 2110
2017
Q4
$2K Sell
96
-9
-9% -$187 ﹤0.01% 2078
2017
Q3
$2K Sell
105
-8
-7% -$152 ﹤0.01% 2047
2017
Q2
$2K Buy
+113
New +$2K ﹤0.01% 2039
2017
Q1
Sell
-50,000
Closed -$393K 2159
2016
Q4
$393K Hold
50,000
﹤0.01% 1370
2016
Q3
$427K Hold
50,000
﹤0.01% 1328
2016
Q2
$584K Hold
50,000
﹤0.01% 1241
2016
Q1
$724K Buy
50,000
+20,000
+67% +$290K ﹤0.01% 1179
2015
Q4
$671K Buy
+30,000
New +$671K ﹤0.01% 1207